Walvax Biotechnology Co. Ltd. | |
Stock Exchange | Shenzhen Stock Exchange |
EPS |
CNY0.69 |
Market Cap |
CNY45 B |
Shares Outstanding |
1.38 B |
Public Float |
724.88 M |
Address |
19/F, Building 9A, Dingyi Tiancheng Kunming Yunnan 650106 China |
Employees | - |
Website | http://www.walvax.com |
Updated | 07/08/2019 |
Walvax Biotechnology Co., Ltd. engages in the research and development, production, and sale of biopharmaceutical products. Its products include haemophilus influenzae type b conjugate vaccine in vials and pre-encapsulation type; lyophilized type A and C, and ACYW135 meningococcal polysaccharide conjugate vaccine. The company was founded on January 16, 2001 and is headquartered in Kunming, China. |